Megakaryocytic protein tyrosine kinases
US6326469A · kind A · utility
121Cited by
1References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 21, 1995 |
| Grant date | Dec 4, 2001 |
| Priority date | — |
| Expiry date | Apr 21, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel cytoplasmic tyrosine kinases isolated from megakaryocytes (megakaryocyte kinases or MKKs) which are involved in cellular signal transduction pathways and to the use of these novel proteins in the diagnosis and treatment of disease. The present invention further relates to specific megakaryocyte kinases, designated MKK1, MKK2 and MKK3, and their use as diagnostic and therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.